A detailed history of Marshall Wace, LLP transactions in Novavax Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 148,917 shares of NVAX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148,917
Previous 362,690 58.94%
Holding current value
$1.2 Million
Previous $4.59 Million 59.05%
% of portfolio
0.0%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.71 - $17.11 $2.29 Million - $3.66 Million
-213,773 Reduced 58.94%
148,917 $1.88 Million
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $1.41 Million - $7.61 Million
362,690 New
362,690 $4.59 Million
Q2 2022

Aug 15, 2022

BUY
$36.28 - $75.29 $5.21 Million - $10.8 Million
143,603 Added 867.48%
160,157 $8.24 Million
Q1 2022

May 16, 2022

SELL
$69.73 - $142.9 $2.02 Million - $4.15 Million
-29,037 Reduced 63.69%
16,554 $1.22 Million
Q4 2021

Feb 14, 2022

BUY
$134.56 - $217.97 $4 Million - $6.48 Million
29,731 Added 187.46%
45,591 $6.52 Million
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $4.45 Million - $6.78 Million
-25,045 Reduced 61.23%
15,860 $3.29 Million
Q2 2021

Aug 13, 2021

SELL
$121.0 - $257.67 $1.19 Million - $2.54 Million
-9,853 Reduced 19.41%
40,905 $8.68 Million
Q1 2021

May 17, 2021

BUY
$112.98 - $319.93 $5.41 Million - $15.3 Million
47,881 Added 1664.27%
50,758 $9.2 Million
Q4 2020

Feb 16, 2021

BUY
$78.74 - $139.5 $226,534 - $401,341
2,877 New
2,877 $321,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.